Who's Buying Horror in 2026: The Most Active Buyers by Signal Volume

Horror is the indie acquisition lane the trade press talks about most and the one writers hear about least clearly. The reality on the ground in 2026 looks like this: A24 is the highest-volume horror buyer by trade-press signal count, with 268 horror-related signals year-to-date through May 26. Lionsgate is second at 153, Focus Features third at 74. The April 2026 horror surge is real: 405 horror signals landed that month against a January count of 144, a near-three-times jump tied directly to the festival and acquisition cycle that ran from Berlin through SXSW and into early Cannes positioning.

That summary is useful but it leaves out one thing every horror writer wants to know: where Blumhouse and Neon sit on this list. The honest answer is that the underlying genre tagging in our canonical data view doesn't fully capture either company's horror activity, even though both are obviously major horror buyers. We address that in the methodology section at the bottom of this piece. For now, the number that matters is that 27 distinct horror buyers logged 5 or more signals in 2026, the pool is wider than the trade press conventional wisdom suggests, and the most-active names are mostly studio-tier and specialty-tier rather than the genre-specialist labels writers usually think of first.

The most active horror buyers, 2026 year-to-date

These are the in-scope buyers (distributors, streamers, sales agents, production companies) tagged "horror" in our canonical genre data, ranked by total trade-press signal volume from January 1 through May 26, 2026. Each row also shows last-30-day and last-90-day activity so you can see who is hot right now versus who built their volume earlier in the year.

| Rank | Buyer | Signals (YTD) | Last 90d | Last 30d | |---|---|---:|---:|---:| | 1 | A24 | 268 | 204 | 49 | | 2 | Lionsgate | 153 | 109 | 43 | | 3 | Focus Features | 74 | 51 | 17 | | 4 | Sony Pictures Television | 49 | 32 | 17 | | 5 | Shudder | 42 | 35 | 4 | | 6 | Sony Pictures | 37 | 25 | 7 | | 7 | Bleecker Street | 21 | 14 | 7 | | 8 | Blue Finch Films (sales agent) | 16 | 12 | 6 | | 9 | Barunson E&A (Korean producer) | 15 | 14 | 7 | | 10 | Well Go USA | 12 | 12 | 3 |

Two reads matter here. A24 leads horror not narrowly but decisively, with nearly double the signal volume of Lionsgate at second place. Sony Pictures Television (a TV-focused arm) is fourth, which tracks the broader 2026 pattern of horror IP moving as readily into series development as into theatrical features. Writers with a horror project that could plausibly run as a limited series or anthology have a buyer pool the trade press rarely lists alongside theatrical horror.

The international names on the list are also significant. Barunson E&A, the South Korean production company behind Parasite, sits at ninth with 15 signals, eight of which landed in the last 30 days. Showbox (sales agent) and Well Go USA (Asian-cinema theatrical distributor) round out the picture: the horror market in 2026 has a real Korean-cinema component that did not exist at this scale five years ago.

The April surge

| Month (2026) | Horror signals | Active horror buyers | |---|---:|---:| | January | 144 | 31 | | February | 141 | 50 | | March | 128 | 39 | | April | 405 | 70 | | May (through May 26) | 263 | 78 |

April's volume jump is the single most visible market signal in horror this year. Three things happened in roughly that window: the SXSW Midnighters slate ran through mid-March and the acquisition tail extended into April; Overlook Film Festival ran late March / early April and surfaced festival-circuit horror acquisitions; and the Cannes pre-market positioning cycle began in earnest, which pulled international sales activity into the visible trade-press feed.

The May number is partial (data runs through May 26, so the month is roughly five days short), and the per-day rate in May is actually higher than April's. The point is that the market did not return to Q1 calm after the April surge. The number of distinct active horror buyers rose from 31 in January to 78 in May, meaning the pool widened materially during the spring window.

What this means for horror writers right now

The realistic top targets are A24, Lionsgate, and Focus Features. Those three companies represent the bulk of the credible horror acquisition surface for an unrepresented or early-career horror writer with a strong spec. Each operates differently: A24 leans into elevated horror with directorial voice and IP-adjacent material (creepypasta, internet-born horror); Lionsgate sits at the higher-budget studio-tier end and reads heavily for genre-with-name-attachment material; Focus Features anchors the prestige-adjacent end where horror crosses into elevated drama.

The international pathway is real. If you have a horror project with international financing, packaging, or talent attached, the Korean and broader Asian distribution market shows up clearly in our data. Barunson E&A, Showbox, and Well Go USA are not the buyers most American writers think to target, but the signal volume says they are reading and acquiring.

Television horror is more open than the trade press headlines. Sony Pictures Television's appearance in fourth place reflects a meaningful pattern: horror IP that could anchor a series is being actively developed by buyers who do not traditionally appear in horror-theatrical roundups.

Festival timing matters disproportionately in this genre. The April surge tied directly to SXSW, Overlook, and pre-Cannes positioning. Writers with a horror project ready to move should know that the strongest reading windows for horror specs and packages typically open in the 4-to-8-week window leading into a major festival and stay open for the 6-to-10 weeks following.

The full horror buyers page lists every horror-tagged buyer with a published profile, and individual profiles for A24, Lionsgate, and Focus Features carry the live activity counts and mandate analysis that this aggregate piece does not get into per-buyer depth on.

Methodology and known limits

Numbers in this report are drawn from trade-press signal aggregation in the ScriptMatch database. A signal is a single attributable mention of a buyer in a public article from a tracked industry publication. One signal is not one deal. One buyer can generate multiple signals from one article when they appear in multiple capacities (acquisition + packaging + executive movement, for example).

The "horror" filter on this analysis pulls every buyer whose canonical genre data includes a horror tag. That filter has known gaps. Blumhouse appears with only 7 horror-tagged signals year-to-date, which is obviously wrong given the company's centrality to the horror market. The reason: Blumhouse's canonical genre data in our aggregation has historically tagged the company as broad-genre rather than horror-specific, even though the bulk of their slate is horror. Neon does not appear on this list at all, which is also wrong given Neon's distribution of Longlegs, Cuckoo, Possessor, and other horror titles. Neon's canonical genre data currently reads as "Drama, International cinema," which excludes the company from this query.

We name these gaps because the alternative is publishing a list that quietly drops two of the most important horror buyers and pretends the gap isn't there. The fix is a canonical-genre-tagging refresh that propagates each buyer's full multi-genre footprint, which is in our active improvement queue. In the interim, treat this list as "the most active horror buyers our genre tagging cleanly captures," not as a complete map. The buyer profiles for A24, Lionsgate, and Focus Features are accurate; the absence of Blumhouse and Neon from the table is a tagging artifact, not a market observation.

The full method behind every claim in this piece is documented on the methodology page. Annual refresh of this report is scheduled for May 2027, with an updated mid-year reading in November 2026.